Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 401–500 of 1,000
Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta
Kazuyama, E., Saito, M., Kinoshita, Y., Satoh, I., Dimitriadis, F., & Satoh, K. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0178-2 · Cited by 41
“and autonomic neuropathy promote vascular dysfunction in diabetes patients [ 6 ].”
BackgroundActivation of the cGMP Signaling Pathway Is Essential in Delaying Oocyte Aging in Diabetes Mellitus,
Goud, A. P., Goud, P. T., Diamond, M. P., Gonik, B., & Abu‐Soud, H. M. (2006) · Biochemistry · doi:10.1021/bi060910e · Cited by 41
Wigg, S. J., Tare, M., Forbes, J. M., Cooper, M. E., Thomas, M. C., Coleman, H. A., Parkington, H. C., & O’Brien, R. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1411-x · Cited by 41
“Abnormal vascular reactivity is a hallmark of the complications of diabetes [1, 2].”
Shah, D. I., & Singh, M. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9273-9 · Cited by 41
“Vascular endothelial dysfunction has been implicated in secondary complications of cardiovascular disorders due to diabetes mellitus (DM) [1], hyperhomocysteinemia (HHcy) [2], hypertension [3] and hypercholesterolemia [4].”
BackgroundThe Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome
Kakafika, A. I., Mikhailidis, D. P., Karagiannis, A., & Athyros, V. G. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299358 · Cited by 39
“These end products are responsible for a range of effects, including quenching nitric oxide and contributing to oxidative stress and inflammatory processes.(84,85) Glycation end products, which undergo receptor-mediated endocytosis into vascular ROLE OF ENDOCANNABINOID SYSTEM BLOCKADE”
BackgroundEl‐Bassossy, H. M., El‐Moselhy, M. A., & Mahmoud, M. F. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0669-z · Cited by 40
“This change in vascular reactivity is responsible for the development of some vascular complications of diabetes (De Vriese et al. 2000).”
BackgroundRetractedVisualization and quantification of mitochondrial structure in the endothelium of intact arteries
Durand, M. J., Ait‐Aissa, K., Levchenko, V., Staruschenko, A., Gutterman, D. D., & Beyer, A. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy294 · Cited by 40
“It is well established that hyperglycaemia induced by STZ injection (which destroys the insulin-producing pancreatic beta cells) causes endothelial dysfunction in both conduit arteries and in the microvasculature (reviewed by De Vriese et al.(7)).”
BackgroundPotential roles of chromium on inflammatory biomarkers in diabetes: A Systematic
Moradi, F., Maleki, V., Saleh‐Ghadimi, S., Kooshki, F., & Gargari, B. P. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13144 · Cited by 40
The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning
Lafuente, N., Matesanz, N., Azcutia, V., Romacho, T., Nevado, J., Rodríguez‐Mañas, L., Moncada, S., Peiró, C., & Sánchez‐Ferrer, C. F. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f331fb · Cited by 40
Jäkälä, P., Hakala, A., Turpeinen, A. M., Korpela, R., & Vapaatalo, H. (2009) · Journal of Functional Foods · doi:10.1016/j.jff.2009.09.003 · Cited by 40
Zehetner, C., Kirchmair, R., Kralinger, M. T., & Kieselbach, G. F. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12081 · Cited by 40
“The metabolic changes in diabetes lead to widespread cellular damage with diabetes-associated microvasculopathy as the pivotal mediator for nephropathy, neuropathy and retinopathy (De Vriese et al. 2000).”
BackgroundShishtar, E., Jovanovski, E., Jenkins, A. L., & Vuksan, V. V. V. (2014) · Clinical Nutrition Research · doi:10.7762/cnr.2014.3.2.89 · Cited by 40
“and increased NO inactivation [30,31], together with evidence from preclinical data, the beneficial AI findings seen with 3 g KWG may be possibly explained by NO driven mechanism stimulated by these ginsenosides, including Rb1, Re, or Rg1, two of which (Re and Rg1) were found to be present in fairly similar”
BackgroundProteinase-Activated Receptor-2 Mediates Arterial Vasodilation in Diabetes
Roviezzo, F., Bucci, M., Brancaleone, V., Lorenzo, A. D., Geppetti, P., Farneti, S., Parente, L., Lungarella, G., Fiorucci, S., & Cirino, G. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184770.01494.2e · Cited by 40
Skov, V., Knudsen, S., Olesen, M., Hansen, M. L., & Rasmussen, L. M. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-15 · Cited by 40
“One element of the generalized alterations in the vasculature in diabetes is endothelial dysfunction [3], characterized by increased permeability [4], increased expression of pro-inflammatory molecules [5], and altered vasomotoric responses [6].”
BackgroundNg, H. H., Leo, C. H., & Parry, L. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.011 · Cited by 40
Gomes, M. B., Affonso, F. S., Cailleaux, S., Almeida, A. L. F., Pinto, L. F. C., & Tibiriçá, E. V. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00248.x · Cited by 40
Fitzgerald, S. M., Kemp‐Harper, B. K., Parkington, H. C., Head, G. A., & Evans, R. G. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00807.2006 · Cited by 40
Bunker, A. K., Arce‐Esquivel, A. A., Rector, R. S., Booth, F. W., Ibdah, J. A., & Laughlin, M. H. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01252.2009 · Cited by 39
“Macro- and microangiopathy are the putative primary causes of morbidity and mortality in subjects with T2DM, and loss of the regulatory role of the vascular endothelium is believed to be an initiating factor in the development of T2DM vascular disease (10).”
BackgroundMechanisms underlying vascular effect of chronic resveratrol in streptozotocin‐diabetic rats
Roghani, M., & Baluchnejadmojarad, T. (2009) · Phytotherapy Research · doi:10.1002/ptr.3032 · Cited by 39
“Our fi ndings were also consistent with previous reports on impaired endothelium-dependent relaxation and enhanced α1-adrenergic receptor mediated contraction in diabetes (De Vriese et al., 2000).”
ResultHyperglycemia-Induced Endothelial Dysfunction
Gerő, D. (2018) · InTech eBooks · doi:10.5772/intechopen.71433 · Cited by 39
“Endothelial dysfunction is primarily responsible for the impaired vasorelaxation in diabetes but it is closely followed by the development of vascular smooth muscle cell dysfunction [10, 11].”
BackgroundUlu, Ş., Bucak, A., Ulu, M. S., Ahsen, A., Duran, A., Yücedağ, F., & Ayçiçek, A. (2013) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-013-2734-3 · Cited by 39
Pathogenesis of diabetic cerebral vascular disease complication
Xu, R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.54 · Cited by 39
The promise of EPC-based therapies on vascular dysfunction in diabetes
Georgescu, A., Alexandru, N., Constantinescu, A. A., Titorencu, I. D., & Popov, D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.035 · Cited by 39
Novel Delivery System for the Bioregulatory Agent Nitric Oxide
Liu, H. A., & Balkus, K. J. (2009) · Chemistry of Materials · doi:10.1021/cm901358z · Cited by 35
Matsumoto, T., Ishida, K., Nakayama, N., Taguchi, K., Kobayashi, T., & Kamata, K. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.003 · Cited by 39
Baluchnejadmojarad, T., & Roghani, M. (2003) · Fitoterapia · doi:10.1016/s0367-326x(03)00158-8 · Cited by 39
Matsumoto, T., Kakami, M., Kobayashi, T., & Kamata, K. (2008) · Peptides · doi:10.1016/j.peptides.2008.04.001 · Cited by 39
Effects of training and nitric oxide on diabetic nephropathy progression in type I diabetic rats
Rodrigues, A. M., Bergamaschi, C. T., Araújo, R. C., Mouro, M. G., Rosa, T. D. S., & Higa, E. M. S. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011005 · Cited by 39
NO and the Vasculature: Where Does It Come from and What Does It Do?
Andrews, K. L., Triggle, C. R., & Ellis, A. (2002) · Heart Failure Reviews · doi:10.1023/a:1020702215520 · Cited by 39
Phương, P. T., Fukuda, D., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Shimabukuro, M., & Sata, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47474-0 · Cited by 38
Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion
Belizaire, R., & Makar, R. S. J. (2020) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2020.09.002 · Cited by 38
“cluding ischemia [104], chronic kidney disease [105], hyperglycemia [106], dyslipidemia[107], trauma[108], inflammation [109], and sepsis”
Abebe, W., & Mozaffari, M. S. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0012-7 · Cited by 38
“Although it has not been determined systematically, the literature generally indicates that, depending upon the type and/or degree of insult, endothelial dysfunction can be more of local or systemic [22, 33, 34].”
BackgroundLeo, C. H., Joshi, A., Hart, J. L., & Woodman, O. L. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.010 · Cited by 38
Nitric oxide and cardiovascular risk factors
Raddino, R., Carretta, G., Teli, M., Bonadei, I., Robba, D., Zanini, G., Madureri, A., Nodari, S., & Cas, L. D. (2007) · Heart International · doi:10.4081/hi.2007.18 · Cited by 38
“As a result of this pathway, more endothelin is produced and inflammation and thrombosis increase (12).”
BackgroundCannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
Stanley, C. P., Wheal, A. J., Randall, M. D., & O’Sullivan, S. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.002 · Cited by 38
Muharis, S. P., Top, A. G. M., Murugan, D. D., & Mustafa, M. R. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.03.005 · Cited by 38
“By scavenging the free radicals, the tocotrienols may have increased the bioavailability of EDNO, allowing normal NO signaling and relaxations.”
InfluentialZhou, W., Wang, X.-L., Kaduce, T. L., Spector, A. A., & Lee, H.-C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00704.2004 · Cited by 38
“Endothelial dysfunction with impaired activity of various endothelium-derived factors plays an integral role in Type 2 diabetes (7).”
BackgroundMatsumoto, T., Wakabayashi, K., Kobayashi, T., & Kamata, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00971.2004 · Cited by 38
“Diabetes mellitus is associated with vascular complications, including impairments of the vascular responsiveness to neurotransmitters in the macro- and microvasculature (10, 13, 48, 49, 68).”
BackgroundJindal, S., Singh, M., & Balakumar, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.05.031 · Cited by 38
“Clinically, the vascular endothelial dysfunction has been associated with various pathological conditions such as hypertension [42], coronary artery diseases [43], diabetes mellitus [44,45], atherosclerosis [46,47] and stroke [48].”
BackgroundOelze, M. W., Schuhmacher, S., & Daiber, A. (2010) · Experimental Diabetes Research · doi:10.1155/2010/213176 · Cited by 37
“Yet only limited knowledge exists about the pathogenesis, the cardiovascular consequences, and the prevention of this disease [1].”
BackgroundEl‐Bassossy, H. M., Dsokey, N., & Fahmy, A. (2014) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2014.945109 · Cited by 37
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
Eid, H. M. A., Reims, H. M., Arnesen, H., Kjeldsen, S. E., Lyberg, T., & Seljeflot, I. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.003 · Cited by 37
“There is growing evidence that endothelial dysfunction is central in the insulin resistance syndrome and type 2 diabetes mellitus [29,30], in which it has been shown that the release and/or bioavailability of NO are diminished [31,32].”
BackgroundProtective effect of resveratrol and quercetin on in vitro-induced diabetic mouse corpus cavernosum
Boydens, C., Pauwels, B., Daele, L. V., & de Voorde, J. V. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0366-9 · Cited by 37
“This demonstrates that Ach-relaxations in mesenteric arteries are EDHF-mediated [11, 25] while in aorta these are NO-mediated.”
BackgroundRole of P2X7 receptors in the development of diabetic retinopathy
Sugiyama, T. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.141 · Cited by 37
Matsumoto, T., Miyamori, K., Kobayashi, T., & Kamata, K. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.02.007 · Cited by 37
Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs
Bell, J., Mosfer, S. I., Lang, D., Donaldson, F., & LEWIS, M. J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1704 · Cited by 37
“It has become increasingly well recognized that oxidative stress plays a crucial role in this process, with many of the diseases where reduced endothelium-derived nitric oxide (NO) activity has been demonstrated also being associated with increased production of oxygen free radicals, particularly superoxide anions (O2…”
BackgroundPieper, G. M., Siebeneich, W., Olds, C. L., Felix, C. C., & Soldato, P. D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00832-8 · Cited by 37
Riad, A. H., Westermann, D., Linthout, S. V., Mohr, Z., Uyulmaz, S., Becher, P. M., Rütten, H., Wohlfart, P., Peters, H., Schultheiss, H.-P., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1159-9 · Cited by 36
“Under diabetic conditions, endothelial dysfunction is a phenomenon that is often recognised in clinical and experimental settings [28, 29].”
BackgroundGenelhu, V. A., Celoria, B. M. J., Duarte, S. F. P., Cabello, P. H., & Francischetti, E. A. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.09.009 · Cited by 36
“Other mechanisms related to chronic abnormalities in lipid and glucosemetabolism, which frequently coexist in insulinresistant obese patients, may also participate in the development of hypertension in those subjects [33,34].”
BackgroundWestermeier, F., Puebla, C., Vega, J. L., Farías, M., Escudero, C., Casanello, P. C., & Sobrevía, L. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109789043900 · Cited by 36
“Gestational diabetes is a syndrome characterized by glucose intolerance, leading to maternal hyperglycaemia, first recognized during pregnancy, that has been associated with abnormal foetal development and perinatal complications, such as macrosomia, neonatal hypoglycaemia, and neurological disorders [6, 10, 34, 66-68…”
BackgroundThe vulnerable blood: Coagulation and clot structure in diabetes mellitus
Hess, K. (2014) · Hämostaseologie · doi:10.5482/hamo-14-09-0039 · Cited by 36
“Altogether this leads to an increased expression of pro-inflammatory cytokines and platelet adhesion molecules (20).”
BackgroundKahlberg, N., Qin, C. X., Anthonisz, J., Jap, E., Ng, H. H., Jelinic, M., Parry, L. J., Kemp‐Harper, B. K., Ritchie, R. H., & Leo, C. H. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.025 · Cited by 36
Leng, B., Li, C., Sun, Y., Zhao, K., Zhang, L., Lü, M., & Wang, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5070415 · Cited by 36
Oxidative Stress in Insulin-Resistant Conditions: Cardiovascular Implications
Stump, C. S., Clark, S. E., & Sowers, J. R. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504060-00003 · Cited by 36
Mukhopadhyay, S., & Mukherjee, T. K. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.03.010 · Cited by 36
R??os-V??zquez, R., Marzoa‐Rivas, R., Gil-Ortega, I., & Kaski, J. C. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606040-00003 · Cited by 36
Triggle, C. R., Ding, H., Anderson, T. J., & Pannirselvam, M. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000041845.62061.c9 · Cited by 36
“Endothelial dysfunction is defined as an impaired endotheliumdependent relaxation (for instance, to acetylcholine) and has been linked to a reduction in the bioavailability/bioactivity of NO in the vessel wall [3].”
BackgroundSharma, B., & Singh, N. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.11.011 · Cited by 35
Matsumoto, T., Yoshiyama, S., Wakabayashi, K., Kobayashi, T., & Kamata, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.044 · Cited by 35
Pharmacological approaches to coronary microvascular dysfunction
Guarini, G., Huqi, A., Morrone, D., Capozza, P., Todiere, G., & Marzilli, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.008 · Cited by 35
Buraczyńska, M., Baranowicz-Gąszczyk, I., Borowicz, E., & Książek, A. (2007) · Nephron Physiology · doi:10.1159/000104874 · Cited by 35
Kolseth, I. B. M., Reine, T. M., Parker, K., Sudworth, A., Witczak, B. J., Jenssen, T. G., & Kolset, S. O. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.029 · Cited by 35
Pathogen Burden in Essential Hypertension
Liu, L., Liu, Y., Tong, W., Ye, H., Zhang, X., Cao, W., & Zhang, Y. (2007) · Circulation Journal · doi:10.1253/circj.71.1761 · Cited by 35
APPLICATIONS OF NANOTECHNOLOGY IN DIABETES
Arya, A. K., Kumar, L., Pokharia, D., & Tripathi, K. (2008) · Cited by 35
Queen, L. R., Ji, Y. H., Goubareva, I., & Ferro, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1219-0 · Cited by 35
“Impairment of the L-arginine/NO pathway in endothelium and/or platelets is common in many cardiovascular disorders, including diabetes mellitus [7, 8, 9, 10, 11, 12].”
BackgroundEffects of exercise training on the vascular reactivity of the whole kidney circulation in rabbits
de Moraes, R., Gioseffi, G., da Nóbrega, A. C. L., & Tibiriçá, E. V. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00923.2003 · Cited by 37
“In this context, endothelium-dependent vasodilation induced by acetylcholine (ACh), which is known to produce NO-dependent vascular relaxation, has been used to characterize endothelium function in different physiological and pathophysiological conditions both in animal and human studies (7).”
BackgroundNg, H. H., Leo, C. H., O’Sullivan, K., Alexander, S.-A., Davies, M. J., Schiesser, C. H., & Parry, L. J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.12.019 · Cited by 34
Paul, W., Queen, L. R., Page, C. P., & Ferro, A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706957 · Cited by 34
Sánchez, A., Contreras, C., Villalba, N., Martínez, M. P., Martínez, A. C., Briones, A. M., Salaíces, M., García-Sacristán, A., Hernández, M., & Prieto, D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00553.x · Cited by 34
Park, H., Kyeong-Ho, Park, D., Lee, H., Chang, H. W., Kim, Y.-S., & Cho, K. H. (2008) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2008.06.004 · Cited by 34
Ahanchi, S. S., Varu, V. N., Tsihlis, N. D., Martínez, J., Pearce, C. G., Kapadia, M. R., Jiang, Q., Saavedra, J. E., Keefer, L. K., Hrabie, J. A., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00185.2008 · Cited by 34
“Investigators have demonstrated that some of the changes that occur as a result of the diabetic environment include reduced bioavailability of nitric oxide (NO) (12), increased reactive oxygen species (ROS) production (30, 46), a proinflammatory milieu (3), MAPK activation (52), protein kinase C activation (30), and a…”
BackgroundKitada, S., Otsuka, Y., Kokubu, N., Kasahara, Y., Kataoka, Y., Noguchi, T., Goto, Y., Kimura, G., & Nonogi, H. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-75 · Cited by 34
“Previous studies have shown that elevated plasma glucose adversely affects endothelium-dependent vasodilation, inflammatory responses, and increases oxidative stress on the cardiovascular system [26-30].”
Modulation of retinal blood flow by kinin B1 receptor in Streptozotocin-diabetic rats
Pouliot, M., Hétu, S., Lahjouji, K., Couture, R., & Vaucher, E. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.03.007 · Cited by 34
“In the retina and many vascular beds, endothelium-dependent vasodilation was found to be diminished in diabetes (De Vriese et al., 2000; Edgley et al., 2008; Oyama et al., 1986; Schmetterer et al., 1997; Tabit et al., 2010; Taylor et al., 1992).”
BackgroundYorek, M. A. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.13 · Cited by 34
“Some of the mechanisms attributed to diabetes-induced endothelium dysfunction include impaired signal transduction pathways or substrate availability, impaired release or increased metabolism of vasodilatory mediators, increased release of vascular constricting factors, and decreased reactivity of the smooth muscle to…”
BackgroundPeng, X., Wang, X., Fan, M., Zhao, J., Liao, L., & Liu, J. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3193 · Cited by 34
The NF-κB/miR-425-5p/MCT4 axis: A novel insight into diabetes-induced endothelial dysfunction
Luo, E., Wang, D., Yan, G., Qiao, Y., Zhu, B., Liu, B., Hou, J., & Tang, C. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110641 · Cited by 34
Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy
Bhatt, L. K., & Veeranjaneyulu, A. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0243-3 · Cited by 34
“Impaired endothelium-dependent vasodilatation has been demonstrated in various vascular beds in diabetic patients and diabetic animals [45, 46].”
BackgroundEdgley, A. J., Tare, M., Evans, R. G., Skordilis, C., & Parkington, H. C. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00861.2007 · Cited by 34
Coppey, L. J., Gellett, J. S., & Yorek, M. A. (2003) · Endothelium · doi:10.1080/10623320303366 · Cited by 34
3′,4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta
Woodman, O. L., & Malakul, W. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.04.012 · Cited by 33
Dobrowolski, C., Clark, E. G., & Sood, M. M. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1437-1 · Cited by 33
Cignarella, A., Minici, C., Bolego, C., Pinna, C., Sanvito, P., Gaion, R. M., & Puglisi, L. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.010 · Cited by 33
The Endothelium in Diabetic Nephropathy
Gilbert, R. E. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0410-8 · Cited by 33
Soucy, K. G., Lim, H. K., Attarzadeh, D. O., Santhanam, L., Kim, J. H., Bhunia, A. K., Sevinç, B., Ryoo, S., Vazquez, M. E., Nyhan, D. P., et al. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00946.2009 · Cited by 34
“Endothelial dysfunction, which is characterized in part by low NO bioavailability and is often a direct consequence of increased oxidative stress, has been observed in hypertension (26), diabetes (7), heart failure (27), and aging (43).”
BackgroundMokhtar, S. S., Vanhoutte, P. M., Leung, S. W. S., Yusof, M. I., Sulaiman, W. A. W., Saad, A. Z. M., Suppıan, R., & Rasool, A. H. G. (2016) · Nitric Oxide · doi:10.1016/j.niox.2015.12.007 · Cited by 33
Self-citationAlam, P., Raka, M. A., Khan, S., Sarker, J., Ahmed, N., Nath, P. D., Hasan, N., Mohib, M. M., Tisha, A., & Sagor, M. A. T. (2018) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2018.09.006 · Cited by 33
Miyamoto, M., Kotani, K., Ishibashi, S., & Taniguchi, N. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/453264 · Cited by 33
Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction
Shah, D. I., & Singh, M. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2005.11.004 · Cited by 33
Constrictor responses of resistance arterioles during diabetes mellitus
Mayhan, W. G., Irvine, S. D., & Sharpe, G. M. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00031-5 · Cited by 33
Essential Role of Bone Marrow for Microvascular Endothelial and Metabolic Functions in Mice
Nakajima, S., Ohashi, J., Sawada, A., Noda, K., Fukumoto, Y., & Shimokawa, H. (2012) · Circulation Research · doi:10.1161/circresaha.112.270215 · Cited by 32
Calderone, V., Rapposelli, S., Martelli, A., Digiacomo, M., Testai, L., Torri, S., Marchetti, P., Breschi, M. C., & Balsamo, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.049 · Cited by 32
Kold‐Petersen, H., Brøndum, E., Nilsson, H., Flyvbjerg, A., & Aalkjær, C. (2012) · Journal of Vascular Research · doi:10.1159/000335487 · Cited by 32
Leo, C., Hart, J. L., & Woodman, O. L. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.018 · Cited by 32
Kobayashi, T., Taguchi, K., Takenouchi, Y., Matsumoto, T., & Kamata, K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.019 · Cited by 32
“Numerous epidemiological studies have indicated that the insulin resistance and hyperinsulinemia associated with diabetes make important contributions to the development of hypertension and cardiovascular diseases, and impaired endothelium-dependent vasodilation has been described both in humans and in animal models o…”
BackgroundHan, X., Wang, B., Sun, Y., Huang, J., Wang, X., Ma, W., Zhu, Y., Xu, R., Jin, H. L., & Liu, N. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01266 · Cited by 32
Elcioğlu, K., Kabasakal, L., Çetınel, Ş., Contuk, G., Sezen, S. F., & Ayanoğlu‐Dülger, G. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.049 · Cited by 32
Matsumoto, T., Kobayashi, T., & Kamata, K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706937 · Cited by 32
“Diabetes mellitus is a strong risk factor for all manifestations of atherosclerotic vascular disease (De Vriese et al., 2000; Luscher et al., 2003).”
BackgroundGenome wide analysis of gene expression changes in skin from patients with type 2 diabetes
Takematsu, E., Spencer, A., Auster, J., Chen, P., Graham, A., Martin, P. E., & Baker, A. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225267 · Cited by 31
“This condition can often lead to the disturbance of the blood vessel wall through promotion of vascular inflammation and endothelial cell dysfunction[2, 3].”
BackgroundQiu, B., Zhou, Y., Tao, X., Hou, X., Du, L., Lv, Y., & Yu, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1347399 · Cited by 31
“Endothelial dysfunction leads to a signi fi cantly increased risk of chronic diseases such as cardiovascular diseases (CVDs) and its associated complications (7, 8), which is a major cause of morbidity and mortality in T2DM patients (9).”
BackgroundJavadzadeh, A., Ghorbanihaghjo, A., Adl, F. H., Andalib, D., Khojasteh, H., & Ghabili, K. (2013) · PubMed Central · Cited by 31
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.